HIV Prevention Clinical Trials Database

A comprehensive source of information on biomedical HIV prevention clinical trials

View Trials Map

Our database allows users to view planned, ongoing, and completed clinical trials around the world, gaining an understanding of the many developments currently being made in the field of HIV prevention research.

Search or Filter

Reset filters

Results

showing 1-8 of 8

Trial Name

VRC 609

Ongoing
Prevention Option
Antibody Related Research
Start Date
June 21, 2018
End Date
December 31, 2022
Population
Cisgender Men, Cisgender Women
Country
United States of America
Product Candidate
VRC-HIVMAB091-00-AB, EDP
Sponsors
NIAID
Trial Name

VRC 611

Ongoing
Prevention Option
Antibody Related Research
Start Date
March 22, 2022
End Date
December 15, 2022
Population
Cisgender Men
Country
United States of America
Product Candidate
CAP256V2LS
Sponsors
NIAID
Trial Name

CAPRISA 012B / SAMBA trial II

Ongoing
Prevention Option
Antibody Related Research
Start Date
April 1, 2020
End Date
December 31, 2022
Population
Cisgender Women
Country
South Africa
Product Candidate
CAP256V2LS, PGT121, VRC07-523LS
Sponsors
EDCTP, SAMRC
Trial Name

CAPRISA 012C / SAMBA trial III

Ongoing
Prevention Option
Antibody Related Research
Start Date
September 14, 2022
End Date
September 14, 2022
Population
Cisgender Women
Country
South Africa
Sponsors
EDCTP
Trial Name

IAVI C100

Ongoing
Prevention Option
Antibody Related Research
Start Date
January 25, 2019
End Date
September 21, 2022
Population
Cisgender Men, Cisgender Women
Country
Kenya, Rwanda, South Africa, Uganda, United States of America
Product Candidate
3BNC117, 10-1074, 10-1074
Sponsors
IAVI
Trial Name

HVTN 805/ HPTN 093

Ongoing
Prevention Option
Antibody Related Research
Start Date
May 18, 2021
End Date
August 12, 2023
Population
Adolescents and Young People, Cisgender Men, Cisgender Women
Country
Botswana, Malawi, South Africa, Zimbabwe
Sponsors
ACTG, HPTN, HVTN, NIAID
Trial Name

SPAN

Ongoing
Prevention Option
Antibody Related Research
Start Date
February 22, 2022
End Date
February 23, 2023
Population
Cisgender Men, Cisgender Women
Product Candidate
rHuPH20, VH3810109
Sponsors
ViiV
Trial Name

EAVI2020 - 01

Ongoing
Prevention Option
Antibody Related Research
Start Date
March 19, 2019
End Date
December 31, 2022
Population
Cisgender Men
Country
United Kingdom
Product Candidate
ConM SOSIP.v7, Mosaic SOSIPs, EDC ConM SOSIP, ConS UFO, EDC ConS UFO
Sponsors
Imperial College London

showing 1-8 of 8